{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 gene mutations are linked to PARK6-linked Parkinson's disease (PD). PINK1 protein localizes to Lewy bodies (LBs) in PD brains, suggesting a role in PD pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the PINK1 G309D variant, linking it to PD pathogenesis through its localization to LBs."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses a cellular model system of LBs, namely induction of aggresomes, to determine how PINK1 can localize to aggregates. This includes immunofluorescence, Western blot analysis, and mitochondrial fractionation studies.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (cellular model system of LBs) effectively models the disease pathogenesis/mechanism defined in Step 1, as it investigates the localization of PINK1 to aggregates, a key feature of PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study includes controls such as wild-type PINK1 and vector alone, and uses multiple replicates (n=3 independent experiments).",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type and vector alone) and multiple replicates were used, meeting the criteria for validity of the specific instances of assays.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study compares the localization and cleavage of wild-type and mutant (G309D) PINK1, demonstrating that the G309D mutation does not affect mitochondrial import and cleavage.",
          "judgment": "Yes",
          "reasoning": "Variant controls (wild-type vs. mutant PINK1) were used, and the study demonstrates that the G309D mutation does not alter the basic mitochondrial import and cleavage of PINK1, suggesting a specific functional impact beyond these processes.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The study does not provide statistical analyses sufficient to estimate or calculate OddsPath for the functional data for the G309D variant.",
          "judgment": "No",
          "reasoning": "No statistical analyses were provided to estimate or calculate OddsPath for the functional data of the G309D variant.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study does not specify the total number of benign/pathogenic variant controls used across the entire study.",
          "judgment": "No",
          "reasoning": "The paper does not provide information on the total number of benign/pathogenic variant controls used, making it impossible to assess the strength based on the number of controls.",
          "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The PINK1 G309D variant's functional evidence supports a pathogenic role in PD, based on its localization to LBs and aggresomes, and its behavior in cellular assays. However, the lack of statistical analysis and unspecified number of controls limits the strength of the evidence to supporting."
    }
  ]
}